 Prognostic indices survival patients temporary devices TAH VAD attempt current indications patient selection criteria use mechanical circulatory support experience patients total artificial heart TAH ventricular assist device VAD centrifugal pump extracorporeal membrane oxigenation ECMO bridge transplantation Group recovery heart failure Group II patients initial hospitalization mechanical support differences preoperative renal hepatic pulmonary functions Postoperative urinary output bilirubin levels variables survival urinary output hours implant discriminative patients Age years modality terminal heart failure acute versus chronic important factors survival bridge group young patients acute decompensation long-term survivors patients years chronic heart failure mechanical support MS postcardiotomy patients duration cardiopulmonary by-pass CPB different survivors bridge recovery groups patients CPB hours MS transplantation weaning conclusion preoperative indices reversibility multiple organ dysfunction remain